Although Mindfulness-based cognitive therapy (MBCT) has been shown to be as effective as anti- depressants in treating depression and anxiety for people who have experienced three or more episodes, the recent ASPIRE study has found that provision of MBCT courses across the UK is patchy. It really is a postcode lottery for access to an MBCT course. Surely, in an era when the NHS is under huge pressure, it makes financial sense if nothing else for MBCT courses to be as widely available as anti-depressants? Not only is it cost-effective but there are also fewer side effects.
mindfulzone.co.uk 